Neurizon Therapeutics Limited carries a market capitalization of 54.98M, placing it among publicly traded companies globally.
| Market Cap | 54.98M |
| Enterprise Value | N/A |
Neurizon Therapeutics Limited's stock has declined approximately -53.54839% over the past 52 weeks. The 50-day moving average sits at 0.07, while the 200-day moving average is 0.09.
| Beta (5Y) | N/A |
| 52-Week Price Change | -53.54839% |
| 50-Day Moving Average | 0.07 |
| 200-Day Moving Average | 0.09 |
| Average Volume (20 Days) | N/A |
Neurizon Therapeutics Limited's most recent stock split took place on February 20, 2019 with a 500:551 split ratio.
| Last Split Date | 2/20/2019 |
| Split Ratio | 500:551 |